Slide 1XML in Pharma – Weve Done SPL, Whats Next? SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES PHILADELPHIA, PA. FEBRUARY 2006 Slide 2 Agenda What…

Slide 11 Two Worlds Converge Pharma/Device Opportunities Challenges Slide 2 2 The Code of Federal Regulations – The Rules – Title 21 defines FDAs responsibilities Online…

Slide 1Increasing Private Investment in R&D: few comments from Chemical Industry (personal View) Dr. Charles G. Bienfait Direction R&T-SOLVAY SA 2007 EU: HLConference…

Slide 1Dr. T. Bedirhan Üstün Coordinator, Classifications, Terminologies, Standards. World Health Organization ICD Slide 2 Background WHO +International Standards ICD Classification…

Slide 1Charles Hulten University of Maryland, NBER & The Conference Board Janet Hao The Conference Board Kirsten Jaeger The Conference Board Intangible Capital and the…

Slide 1INVESTIGATING CORRUPTION IN CHINA – RECENT DEVELOPMENTS AND PRACTICAL EXPERIENCES Keith Williamson, Managing Director, Alvarez & Marsal Andrew Dale, Partner,…

Slide 1 1 INDIA-CIS PHARMA & HEALTH CONFERENCE MUMBAI 3 rd MARCH, 2006 Department of Chemicals & Petrochemicals Ministry of Chemicals & Fertilizers Government…

Slide 1 NHS Research Scotland -Overview -Feasibility -R&D permissions Dr Alison Walker National Coordinator, NRS Permissions CC Commercial presentation Slide 2 NHS Research…

Slide 1 ©CMBI 2005 Bioinformatics New Integrating Across borders Problem oriented Theory and practice Not very difficult… Slide 2 ©CMBI 2005 Bio + informatics Slide 3…

Slide 1 Super fast identification and optimization of high quality drug candidates Slide 2 Our Goals  Constructing highly enriched and efficient molecular libraries for…